Pacific Biosciences (PACB) Gets a Hold from Piper Sandler
In a report released today, David Westenberg from Piper Sandler reiterated a Hold rating on Pacific Biosciences (PACB – Research Report), with ...
The Goldman Sachs Group Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $1.50
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price target dropped by research analysts at The ...
Pacific Biosciences of California Sees Unusually High Options Volume (NASDAQ:PACB)
Pacific Biosciences of California, Inc. (NASDAQ:PACB – Get Free Report) was the target of unusually large options trading activity on Tuesday. Investors acquired 31,944 call options on the stock. This ...
Morgan Stanley Sticks to Its Hold Rating for Pacific Biosciences (PACB)
Morgan Stanley analyst Tejas Savant maintained a Hold rating on Pacific Biosciences (PACB – Research Report) today and set a price target of ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) Q4 2024 Earnings Call Transcript
Q4 2024 Earnings Call Transcript February 13, 2025 Pacific Biosciences of California, Inc. beats earnings expectations.
Pacific Biosciences: Q4 Earnings Snapshot
MENLO PARK, Calif. (AP) — MENLO PARK, Calif. (AP) — Pacific Biosciences of California Inc. (PACB) on Thursday reported fourth-quarter profit of $3.6 million. The Menlo Park, California-based company ...
Pacific Biosciences of California Inc (PACB) Q4 2024 Earnings Report Preview: What To Expect
Pacific Biosciences of California Inc (NASDAQ:PACB) is set to release its Q4 2024 earnings on Feb 13, 2025. The consensus ...
Pacific Biosciences of California Full Year 2024 Earnings: EPS Beats Expectations
Full Year 2024 Results Key Financial Results Revenue: US$154.0m ...